Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | THPO | P40225 | 2/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.50 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA3 | P07451 | 3/20 | 0.50 |
| ▸ | CA4 | P22748 | 3/20 | 0.50 |
| ▸ | CA6 | P23280 | 3/20 | 0.50 |
| ▸ | CA5A | P35218 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3346776 | 0.96 | DNM1 (0.57) | NFKB1TSHRTHPODNM1CA12 | |
| SCHEMBL3355384 | 0.96 | DNM1 (0.57) | NFKB1TSHRTHPODNM1CA12 | |
| SCHEMBL3350152 | 0.96 | DNM1 (0.57) | NFKB1TSHRTHPODNM1CA12 | |
| SCHEMBL3348447 | 0.96 | DNM1 (0.57) | NFKB1TSHRTHPODNM1CA12 | |
| Hydrochloric Acid SCHEMBL6832653 | 0.96 | MAPT (0.56) | NFKB1TSHRTHPODNM1CA12 | |
| SCHEMBL3350257 | 0.96 | DNM1 (0.57) | NFKB1TSHRTHPODNM1CA12 | |
| Hydrochloric Acid SCHEMBL5325306 | 0.93 | DNM1 (0.53) | NFKB1TSHRTHPODNM1CA12 | |
| Hydrochloric Acid SCHEMBL10810690 | 0.93 | DNM1 (0.53) | NFKB1TSHRTHPODNM1CA12 | |
| Hydrochloric Acid SCHEMBL10809136 | 0.93 | DNM1 (0.53) | NFKB1TSHRTHPODNM1CA12 | |
| Hydrochloric Acid SCHEMBL10808301 | 0.93 | DNM1 (0.53) | NFKB1TSHRTHPODNM1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150150994-A1 | LIVER TARGETED DRUG DELIVERY SYSTEMS USING METAL NANOPARTICLES AND PREPARING METHOD THEREOF | POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) | 2015-06-04 | — | — | US | claimed |
| US-11718698-B2 | Polyolefin grafted polydiene polymers, and methods of making and using same | BRIDGESTONE CORPORATION (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210230420-A1 | Polyolefin Grafted Polydiene Polymers, And Methods Of Making And Using Same | BRIDGESTONE CORPORATION (JP) | 2021-07-29 | — | — | US | disclosed |
| EP-3397666-B1 | POLYOLEFIN GRAFTED POLYDIENE POLYMERS, AND METHODS OF MAKING AND USING SAME | BRIDGESTONE CORP (JP) | 2020-08-26 | — | — | EP | disclosed |
| CN-108473635-B | Polyolefin grafted polydiene polymers and methods of making and using the same | 株式会社普利司通 | 2020-08-25 | — | — | CN | disclosed |
| EP-2142485-B1 | METALLIC SURFACE ENHANCEMENT | MACDERMID ENTHONE INC (US) | 2019-07-24 | — | — | EP | disclosed |
| US-20180362695-A1 | Polyolefin Grafted Polydiene Polymers, And Methods Of Making And Using Same | BRIDGESTONE CORPORATION (JP) | 2018-12-20 | — | — | US | disclosed |
| EP-3397666-A1 | POLYOLEFIN GRAFTED POLYDIENE POLYMERS, AND METHODS OF MAKING AND USING SAME | Bridgestone Corporation (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-10029014-B2 | Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2018-07-24 | — | — | US | disclosed |
| WO-2017117325-A1 | POLYOLEFIN GRAFTED POLYDIENE POLYMERS, AND METHODS OF MAKING AND USING SAME | BRIDGESTONE CORPORATION (JP) | 2017-07-06 | — | — | WO | disclosed |
| US-8741390-B2 | Metallic surface enhancement | ENTHONE INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-8323741-B2 | Self assembled molecules on immersion silver coatings | CITIBANK, N.A. | 2012-12-04 | — | — | US | disclosed |
| US-20120276409-A1 | SELF ASSEMBLED MOLECULES ON IMMERSION SILVER COATINGS | ENTHONE INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-8216645-B2 | Self assembled molecules on immersion silver coatings | ENTHONE INC. (US) | 2012-07-10 | — | — | US | disclosed |
| EP-2222416-A1 | SELF ASSEMBLED MOLECULES ON IMMERSION SILVER COATINGS | Enthone, Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| US-20100151263-A1 | METALLIC SURFACE ENHANCEMENT | ENTHONE INC. (US) | 2010-06-17 | — | — | US | disclosed |
| EP-2142485-A1 | METALLIC SURFACE ENHANCEMENT | Enthone, Inc. (US) | 2010-01-13 | — | — | EP | disclosed |
| US-20090121192-A1 | SELF ASSEMBLED MOLECULES ON IMMERSION SILVER COATINGS | ENTHONE INC. (US) | 2009-05-14 | — | — | US | disclosed |
| WO-2009062139-A1 | SELF ASSEMBLED MOLECULES ON IMMERSION SILVER COATINGS | ENTHONE INC. (US) | 2009-05-14 | — | — | WO | disclosed |
| WO-2008131206-A1 | METALLIC SURFACE ENHANCEMENT | ENTHONE INC. (US) | 2008-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150150994-A1 | LIVER TARGETED DRUG DELIVERY SYSTEMS USING METAL NANOPARTICLES AND PREPARING METHOD THEREOF | FABP1, CD44, HDGF | NFKB1 2017/4885TSHR 852/4885THPO 2745/4885 |
| US-10029014-B2 | Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery | TIE1, DNM2, DNM1 | NFKB1 3611/4885TSHR 2088/4885THPO 1495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.